October 2015 | Oncology Business News®

An Age of Exciting New Medicine That Many Cannot Afford

October 12, 2015

Consolidation in the insurance industry and the pace of the rise in cost of general and specialty pharmaceuticals are the 2 factors in the healthcare industry that will most affect access and affordability.

Practices Ill-Equipped for Patient Financial Needs

October 04, 2015

The swift increase of cancer care costs has created difficulties for independent oncology practices, but the largest of the challenges may be finding a financially sustainable way to provide good care to patients who cannot pay all of their own bills.

Drug Shortages Persist Despite FDA Push for More Information

October 01, 2015

The door isn't fully closed on the acute oncology drug shortages of 4 years ago, observers say, though the FDA has established rules for greater disclosure by manufacturers and continues to tweak guidelines that would require far more information about manufacturing processes and production issues.

Bundled Care Has Power to Rein In Drug Price Escalation

September 30, 2015

The attempt by Turing Pharmaceuticals to boost the price of the anti-parasitic pyrimethamine (Daraprim) 5500% is now under reconsideration, but it shows up the flaws inherent in a fragmented payment system.